Aralez pharmaceuticals inc. (ARLZ)
Income statement / Quarterly
Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15Mar'15
Revenues:
Product revenues, net

-

-

9,462

8,768

-

6,434

8,058

7,375

3,565

-

-

-

Other revenues

-

-

14,876

18,850

-

13,573

5,570

5,203

4,492

5,820

5,201

4,404

Total revenues, net

-

-

24,338

27,618

-

20,007

13,628

12,578

8,057

5,820

5,201

4,404

Product
Other
Revenues:
Revenues

38,081

-

-

-

25,969

-

-

-

-

-

-

-

Costs and expenses:
Cost of product revenues (exclusive of amortization shown separately below)

11,536

-

-

-

2,756

-

-

-

-

-

-

-

Cost of product revenues (exclusive of amortization shown separately below)

-

-

3,054

2,948

-

2,505

3,362

3,360

2,538

-

-

-

Selling, general and administrative

26,502

28,806

24,686

32,234

30,846

32,913

25,445

22,731

37,459

12,207

18,193

3,262

Research and development

37

766

736

728

94

909

2,037

1,474

4,412

1,806

2,302

984

Amortization of intangible assets

8,990

-

-

-

8,513

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

8,671

8,534

-

6,767

2,418

2,134

1,272

-

-

-

Change in fair value of contingent consideration

5,085

23,056

4,632

3,594

4,443

-

-

-

-

-

-

-

Total costs and expenses

52,150

65,981

41,779

48,038

46,652

48,212

33,262

29,699

45,681

-

-

-

Total costs and expenses

-

-

-

-

-

-

-

-

-

14,013

20,495

4,246

Loss from operations

-14,069

-37,959

-17,441

-20,420

-20,683

-28,205

-19,634

-17,121

-37,624

-8,193

-15,294

158

Interest expense

6,658

6,801

6,803

6,727

6,653

-

495

593

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-307

-

-

-

Other income (expense), net

-212

78

84

109

411

1,329

-173

-270

4,797

17

15

-186

Loss before income taxes

-20,939

-44,682

-24,160

-27,038

-26,925

-31,622

-20,302

-17,984

-33,134

-8,176

-15,279

-28

Income tax expense (benefit)

-1,198

1,085

281

482

552

-506

297

-509

654

-27

1,001

-

Net loss

-

-

-

-

-

-

-

-

-33,788

-8,149

-16,280

-28

Net loss

-19,741

-45,767

-24,441

-27,520

-27,477

-

-20,599

-17,475

-

-

-

-

Basic net loss per common share (in dollars per share)

-0.29

-0.68

-0.37

-0.42

-0.42

-0.43

-0.32

-0.27

-0.65

-0.25

-0.50

0.00

Diluted net loss per common share (in dollars per share)

-0.29

-0.68

-0.37

-0.42

-0.42

-0.42

-0.32

-0.27

-0.73

-0.25

-0.50

0.00

Shares used in computing basic net loss per common share

67,025

66,919

66,837

66,110

65,690

65,579

65,229

64,360

52,156

32,732

32,436

32,259

Shares used in computing diluted net loss per common share

67,025

66,919

66,837

66,110

65,690

65,449

65,229

64,363

52,491

32,732

32,436

32,259